Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
NLRP3 Inflammasome and MS/EAE.
Targeting erythropoietin for chronic neurodegenerative diseases.
EXPRESSION OF CONCERN: The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
Social support, depression, and physical disability: Age and diagnostic group effects.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
The genetics of multiple sclerosis: review of current and emerging candidates.
Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
Nature plus nurture: the triggering of multiple sclerosis.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Is It Too Early to Predict the Failure of Natalizumab in NMO?
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
The effectiveness of fingolimod in a Portuguese real-world population.
Brain atrophy at onset and physical disability in multiple sclerosis.
Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.

Pages